Quelles stratégies thérapeutiques employer dans les pays émergents ?
Joseph GLIGOROV
Oncologue, Paris, France
New User? Click here to register
Initially, Perry J. PICKHARDT research focused on a smaller cohort of around 10,000 healthy outpatient adults undergoing routine screening. This was subsequently expanded to include the center’s full cohort of approximately 150,000 patients. Now, they are extending this work to centers across the United States and globally, amassing a database of over a million unique patients.
The extensive reach of the project allows to gather data from individuals representing various racial, ethnic, geographic, and socioeconomic backgrounds. This diverse dataset will enable to identify normal versus abnormal patterns specific to each individual’s demographic, taking into account factors like age, sex, and race.
The primary focus is on the main body composition measures such as bone, muscle, fat, vascular calcium, and liver measurements. We are also exploring other organs like the pancreas and kidneys, but the main emphasis is on osteoporosis, cardiovascular disease, sarcopenia, and metabolic syndrome, which encompasses diabetes.
By analyzing data from a diverse population, Perry J. PICKHARDT aim to gain a more accurate understanding of what constitutes normal and abnormal for an individual within their specific demographic. This will help medical professionals provide more personalized care and improve overall patient outcomes.
Text generated by AI based on an exclusive interview, revised and reviewed by
Joseph GLIGOROV
Oncologue, Paris, France
Jean-Jacques ZAMBROWSKI
Copyright © 2025 - BCU